BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 37448282)

  • 1. Prediction of diabetes mellitus after kidney transplantation using patient-specific induced pluripotent stem cells.
    Lim SW; Shin YJ; Cui S; Ko EJ; Chung BH; Yang CW
    Kidney Res Clin Pract; 2024 Mar; 43(2):236-249. PubMed ID: 37448282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. I. How can you choose the fate of iPSCs and stem cells, Regeneration or Carcinogenesis? A hypothetical insight.: II. Modelling human beta cell development with pluripotent stem cells.
    Seno M; Nostro MC
    J Stem Cells Regen Med; 2020; 16(2):90-91. PubMed ID: 33414585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in the Generation of β-Cells from Induced Pluripotent Stem Cells as a Potential Cure for Diabetes Mellitus.
    Agrawal A; Narayan G; Gogoi R; Thummer RP
    Adv Exp Med Biol; 2021; 1347():1-27. PubMed ID: 34426962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient generation of functional pancreatic β-cells from human induced pluripotent stem cells.
    Yabe SG; Fukuda S; Takeda F; Nashiro K; Shimoda M; Okochi H
    J Diabetes; 2017 Feb; 9(2):168-179. PubMed ID: 27038181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model.
    Jeon K; Lim H; Kim JH; Thuan NV; Park SH; Lim YM; Choi HY; Lee ER; Kim JH; Lee MS; Cho SG
    Stem Cells Dev; 2012 Sep; 21(14):2642-55. PubMed ID: 22512788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances in Disease Modeling and Drug Discovery for Diabetes Mellitus Using Induced Pluripotent Stem Cells.
    Kawser Hossain M; Abdal Dayem A; Han J; Kumar Saha S; Yang GM; Choi HY; Cho SG
    Int J Mol Sci; 2016 Feb; 17(2):256. PubMed ID: 26907255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
    El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
    Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of pancreatic insulin-producing cells from rhesus monkey induced pluripotent stem cells.
    Zhu FF; Zhang PB; Zhang DH; Sui X; Yin M; Xiang TT; Shi Y; Ding MX; Deng H
    Diabetologia; 2011 Sep; 54(9):2325-36. PubMed ID: 21755313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Transplantation Resistance of Type II Diabetes Mellitus Adipose-Derived Stem Cells Is Due to G6PC and IGF1 Genes Related to the FoxO Signaling Pathway.
    Horiguchi M; Turudome Y; Ushijima K
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34205470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-transplant diabetes mellitus: risk factors, frequency of transplant rejections, and long-term prognosis.
    Schiel R; Heinrich S; Steiner T; Ott U; Stein G
    Clin Exp Nephrol; 2005 Jun; 9(2):164-9. PubMed ID: 15980953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA-690 regulates induced pluripotent stem cells (iPSCs) differentiation into insulin-producing cells by targeting Sox9.
    Xu Y; Huang Y; Guo Y; Xiong Y; Zhu S; Xu L; Lu J; Li X; Wan J; Lu Y; Wang Z
    Stem Cell Res Ther; 2019 Feb; 10(1):59. PubMed ID: 30767782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of iPSC-derived insulin-producing cells from patients with type 1 and type 2 diabetes compared with healthy control.
    Kim MJ; Lee EY; You YH; Yang HK; Yoon KH; Kim JW
    Stem Cell Res; 2020 Oct; 48():101958. PubMed ID: 32882526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes Mellitus Is a Chronic Disease that Can Benefit from Therapy with Induced Pluripotent Stem Cells.
    Arroyave F; Montaño D; Lizcano F
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33217903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of different pancreatic microenvironments on improvement in hyperglycemia and insulin deficiency in diabetic rats after transplantation of allogeneic mesenchymal stromal cells.
    Katuchova J; Tothova T; Farkasova Iannaccone S; Toporcer T; Harvanova D; Hildebrand T; Kilik R; Bacenkova D; Frohlichova L; Rosocha J; Bobrov N; Radonak J
    J Surg Res; 2012 Nov; 178(1):188-95. PubMed ID: 22480834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide analysis of PDX1 target genes in human pancreatic progenitors.
    Wang X; Sterr M; Burtscher I; Chen S; Hieronimus A; Machicao F; Staiger H; Häring HU; Lederer G; Meitinger T; Cernilogar FM; Schotta G; Irmler M; Beckers J; Hrabě de Angelis M; Ray M; Wright CVE; Bakhti M; Lickert H
    Mol Metab; 2018 Mar; 9():57-68. PubMed ID: 29396371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes.
    Kudva YC; Ohmine S; Greder LV; Dutton JR; Armstrong A; De Lamo JG; Khan YK; Thatava T; Hasegawa M; Fusaki N; Slack JM; Ikeda Y
    Stem Cells Transl Med; 2012 Jun; 1(6):451-61. PubMed ID: 23197849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Proinflammatory Markers in Patients After Kidney Transplantation in Relation to the Presence of Diabetes.
    Cieniawski D; Miarka P; Ignacak E; Bętkowska-Prokop A; Waluś-Miarka M; Idzior-Waluś B; Kuźniewski M; Sułowicz W
    Transplant Proc; 2016 Jun; 48(5):1604-7. PubMed ID: 27496454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diazoxide preconditioning of endothelial progenitor cells from streptozotocin-induced type 1 diabetic rats improves their ability to repair diabetic cardiomyopathy.
    Ali M; Mehmood A; Anjum MS; Tarrar MN; Khan SN; Riazuddin S
    Mol Cell Biochem; 2015 Dec; 410(1-2):267-79. PubMed ID: 26359087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysfunctional pancreatic cells differentiated from induced pluripotent stem cells with mitochondrial DNA mutations.
    So S; Lee S; Lee Y; Han J; Kang S; Choi J; Kim B; Kim D; Yoo HJ; Shim IK; Oh JY; Lee YN; Kim SC; Kang E
    BMB Rep; 2022 Sep; 55(9):453-458. PubMed ID: 35651332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transplant diabetes mellitus: is it associated with poor allograft outcomes in renal transplants?
    Choi JY; Kwon OJ
    Transplant Proc; 2013 Oct; 45(8):2892-8. PubMed ID: 24156999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.